In the BioHarmony Drug Report Database
Prasugrel
Effient, Efient (prasugrel) is a small molecule pharmaceutical. Prasugrel was first approved as Effient on 2009-02-24. It has been approved in Europe to treat acute coronary syndrome, myocardial infarction, and unstable angina.
Trade Name
|
Efient |
|---|---|
Common Name
|
prasugrel |
ChEMBL ID
|
CHEMBL1201772 |
Indication
|
acute coronary syndrome, myocardial infarction, unstable angina |
Drug Class
|
Platelet aggregation inhibitors |
Image (chem structure or protein)